Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori, K Nakao, K Asami… - Medical oncology, 2013 - Springer
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …
被引用次数：64 相关文章

Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori, K Nakao… - Medical …, 2013 - search.proquest.com
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …

Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.

M Tamiya, A Tamiya, T Yamadori, K Nakao… - Medical Oncology …, 2013 - europepmc.org
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …

Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori… - Medical oncology …, 2013 - pubmed.ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …

[引用][C] Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori, K Nakao, K Asami… - Medical …, 2013 - cir.nii.ac.jp
Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with
malignant pleural effusion | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori, K Nakao, K Asami… - Medical Oncology, 2013 - infona.pl
Vascular endothelial growth factor (VEGF) is involved in non-small cell lung cancer
(NSCLC) with malignant pleural effusion (MPE), but little is known regarding the efficacy of …

[引用][C] Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

M Tamiya, A Tamiya, T Yamadori, K Nakao, K Asami… - Medical oncology, 2013 - Springer